Skip to main content
. 2014 Apr 29;28(8):1203–1211. doi: 10.1097/QAD.0000000000000273

Table 1.

Sociodemographic and clinical characteristics of adults with HIV diagnosis for at least 12 months and receiving medical care in the United States, Medical Monitoring Project, 2009.

Characteristic Totala (n = 4094) MSM (n = 1897) MSW (n = 1016) WSM (n = 1093) P for modified Rao-Scott chi-square test
Weighted % (95% CI) Weighted % (95% CI) Weighted % (95% CI) Weighted % (95% CI)
Age at the time of interview (years)
 18–29 7 (6–8) 8 (6–9) 4 (2–5) 9 (7–11) <0.001
 30–39 17 (15–18) 16 (14–18) 12 (10–15) 21 (18–24)
 40–49 40 (38–42) 41 (39–44) 39 (36–42) 39 (35–43)
 ≥50 36 (35–38) 35 (33–38) 45 (42–49) 31 (28–34)
Race/ethnicity
 Black, non-Hispanic 41 (33–49) 22 (16–28) 56 (46–67) 62 (54–70) <0.001
 White, non-Hispanic 35 (28–41) 54 (48–61) 17 (11–23) 18 (14–22)
 Hispanic 19 (14–24) 19 (16–22) 22 (13–32) 17 (10–24)
 Multiracial/other 5 (4–6) 5 (4–6) 5 (3–7) 3 (2–5)
Education
 <High school 23 (20–25) 9 (7–11) 36 (33–40) 34 (31–38) <0.001
 High school 27 (24–30) 22 (19–24) 34 (31–37) 30 (26–34)
 >High school 50 (46–55) 69 (65–74) 30 (25–34) 36 (32–40)
At or below the poverty levelb 44 (40–48) 26 (23–29) 58 (54–62) 62 (57–67) <0.001
Experienced homelessnessb 9 (8–10) 6 (5–8) 14 (11–16) 8 (7–10) <0.001
In jail >24 hb 6 (5–7) 3 (3–4) 11 (8–14) 5 (4–7) <0.001
Continuous health insurance or coverageb 72 (67–76) 72 (66–78) 71 (65–76) 74 (69–79) 0.238
HIV diagnosis 5 years earlier 78 (76–80) 78 (75–80) 77 (74–81) 80 (77–83) 0.444
Prescribed antiretroviral therapy 89 (88–91) 90 (89–92) 91 (89–93) 86 (83–89) 0.006
3 viral load measurementsb 62 (60–65) 61 (59–64) 66 (62–71) 60 (56–64) 0.236
All viral load measures in the past year <200 copies/ml 59 (56–62) 63 (60–66) 58 (54–62) 53 (49–57) <0.001
Clinical status
 AIDS or CD4+ cell count 0–199 cells/μl (nadir) 68 (66–70) 65 (63–68) 76 (73–80) 65 (62–68) <0.001
 No AIDS and CD4+ cell count 200–499 cells/μl (nadir) 25 (23–27) 28 (25–31) 18 (15–21) 27 (24–29)
 No AIDS and CD4+ cell count ≥500 cells/μl (nadir) 7 (6–8) 7(5–9) 5 (4–7) 8 (6–10)

CI, confidence interval; MSM, men have sex with men; MSW, men who have sex with women; WSM, women who have sex with men.

aExcludes persons who reported no sexual behaviour and did not report their sexual orientation as heterosexual, homosexual or bisexual. Includes transgender participants (n = 64) and women who have sex with women (n = 26) because sample sizes were too small to provide valid estimates for separate analysis.

bRefers to the 12 months before interview (June 2008–May 2009).